Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Purification
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogène
This HK2 (Hexokinase II) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 453-483 amino acids from the Central region of human HK2 (Hexokinase II).
HK2
Reactivité: Humain
WB, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
WB: 1:1000. IHC-P: 1:100. IHC-P: 1:100
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Date de péremption
6 months
Kiritsy, Antoniades, Carlson, Beaulieu, DAndrea, Lynch et al.: "Combination of platelet-derived growth factor-BB and insulin-like growth factor-I is more effective than platelet-derived growth factor-BB alone in stimulating complete healing of full-thickness..." dans: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, Vol. 3, Issue 3, pp. 340-50, (2006) (PubMed).
Kuwabara, Ishikawa, Kobayashi, Kobayashi, Sugiyama: "Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats." dans: Pharmaceutical research, Vol. 12, Issue 10, pp. 1466-9, (1996) (PubMed).
Laakso, Malkki, Deeb: "Amino acid substitutions in hexokinase II among patients with NIDDM." dans: Diabetes, Vol. 44, Issue 3, pp. 330-4, (1995) (PubMed).
Echwald, Bjørbaek, Hansen, Clausen, Vestergaard, Zierath, Printz, Granner, Pedersen: "Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity." dans: Diabetes, Vol. 44, Issue 3, pp. 347-53, (1995) (PubMed).
Shinohara, Yamamoto, Kogure, Ichihara, Terada: "Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines." dans: Cancer letters, Vol. 82, Issue 1, pp. 27-32, (1994) (PubMed).
In vertebrates there are four major glucose-phosphorylating isoenzymes, designated hexokinase I, II, III, and IV. Hexokinase is an allosteric enzyme inhibited by its product GLC-6-P. Hexokinase activity is involved in the first step in several metabolic pathways. HK3 is bound to the outer mitochondrial membrane. Its hydrophobic N-terminal sequence may be involved in membrane bindng. It is the predominant hexokinase isozyme expressed in insuline-responsive tissues such as skeletal muscle. The N- and C-terminal halves of this hexokinase show extensive sequence similarity to each other. The catalytic activity is associated with the C-terminus while regulatory function is associated wiht the N-terminus. Although found in NIDDM patients, genetic variations of HK2 do not contribute to the disease.